The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy

References

• Centers for Disease Control and Prevention. Global cancer statistics. Available from: http://www.cdc.gov/cancer/international/statistics.htm. Accessed 513, 2016.
   Google Scholar
• World Health Organization. Human papillomavirus (HPV) and cervical cancer. Available from: http://www.who.int/mediacentre/factsheets/fs380/en/. Accessed 727, 2021.
   Google Scholar
• Li X, Huang K, Zhang Q, et al. Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer. Oncotargets. 2016;7:87485–87495. doi:10.18632/oncotarget.11460
   PubMedGoogle Scholar
• Britten RA, Evans AJ, Allalunis-Turner MJ, et al. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol. 1996;39:145–153. doi:10.1016/0167-8140(96)01719-78735482
   PubMed Web of Science ®Google Scholar
• Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843–847. doi:10.1016/j.mri.2005.11.00516916701
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Saunders MI, Goodchild K, et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol. 1999;72:1093–1098. doi:10.1259/bjr.72.863.1070082710700827
   PubMed Web of Science ®Google Scholar
• Hyulton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy-results from ACRIN 6657/I-SPY TRIAL. Radiology. 2012;263:663–672. doi:10.1148/radiol.1211074822623692
   PubMed Web of Science ®Google Scholar
• Heethuis SE, van Rossum PSN, Lips IM, et al. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiation. Radiother Oncol. 2016;120:128–135. doi:10.1016/j.radonc.2016.05.00927296409
   PubMed Web of Science ®Google Scholar
• Mayr NA, Yuh WTC, Zheng J, et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys. 1997;39:395–404. doi:10.1016/S0360-3016(97)00318-09308943
   PubMed Web of Science ®Google Scholar
• Noh JM, Park W, Huh SJ, et al. Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients. Radiat Oncol J. 2012;30:218–225. doi:10.3857/roj.2012.30.4.21823346542
   PubMedGoogle Scholar
• Lee KC, Kim HJ, Sung K, et al. The predictive value of tumor size, volume, and markers during radiation therapy in patients with cervical cancer. Int J Gynecol Cancer. 2017;27:123–130. doi:10.1097/IGC.000000000000083727668394
   PubMed Web of Science ®Google Scholar
• Lee J, Lee J, Choi J, et al. Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer. Radiat Oncol J. 2015;33:117–125. doi:10.3857/roj.2015.33.2.11726157681
   PubMedGoogle Scholar
• Osumi H, Takahari D, Shinozaki E, et al. Association between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer. Gastric Cancer. 2018;21:267–275. doi:10.1007/s10120-017-0729-228584889
   PubMed Web of Science ®Google Scholar
• Kim S, Loevener LA, Quon H, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2010;31:262–268. doi:10.3174/ajnr.A181719797785
   PubMed Web of Science ®Google Scholar
• Chawla S, Kim S, Loevner LA, et al. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2011;32:778–784. doi:10.3174/ajnr.A237621349969
   PubMed Web of Science ®Google Scholar
• McLaughlin R, Hylton N. MRI in breast cancer therapy monitoring. NMR Biomed. 2011;24:712‑720.
   Web of Science ®Google Scholar
• Tong T, Sun Y Y, Gollub MJ, et al. Dynamic contrast enhanced MRI: use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging. 2015;42:673–680. doi:10.1002/jmri.2483525652254
   PubMed Web of Science ®Google Scholar
• Intven M, Reerink O, Philippens ME. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. J Magn Reson Imaging. 2015;41:1646–1653. doi:10.1002/jmri.2471825124320
   PubMed Web of Science ®Google Scholar
• King AD, Thoeny HC. Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging. 2016;16:23. doi:10.1186/s40644-016-0080-627542718
   PubMed Web of Science ®Google Scholar
• Shukla-Dave A, Lee NY, Jansen JF, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys. 2012;82:1837–1844. doi:10.1016/j.ijrobp.2011.03.00621601373
   PubMed Web of Science ®Google Scholar
• Jansen JF, Scho¨der H, Lee NY, et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Boil Phys. 2010;77:1403–1410. doi:10.1016/j.ijrobp.2009.07.009
   PubMed Web of Science ®Google Scholar
• Lee HY, Kim N, Goo JM, et al. Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model. Diagn Interv Radiol. 2016;22:231–240. doi:10.5152/dir.2015.1517127023149
   PubMed Web of Science ®Google Scholar
• Sun NN, Liu C, Ge XL, et al. Dynamic contrast-enhanced MRI for advanced esopharyngeal cancer response assessment after concurrent chemoradiotherapy. Diagn Interv Radiol. 2018;24:195–202. doi:10.5152/dir.2018.1736930091709
   PubMed Web of Science ®Google Scholar
• Gollub MJ, Gultekin DH, Akin O, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol. 2012;22:821–831. doi:10.1007/s00330-011-2321-122101743
   PubMed Web of Science ®Google Scholar
• Semple SIK, Harry VN, Parkin D, et al. A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2009;75:611–617. doi:10.1016/j.ijrobp.2009.04.06919735887
   PubMed Web of Science ®Google Scholar
• Zahra MA, Tan LT, Priest AN, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766–773. doi:10.1016/j.ijrobp.2008.08.02319019563
   PubMed Web of Science ®Google Scholar
• Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54:759–767. doi:10.1016/S0360-3016(02)02972-312377328
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Yamada Y, Tateishi U, et al. Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis. Int J Cancer. 2012;30:2359–2365. doi:10.1002/ijc.26282
   Web of Science ®Google Scholar
• De Bruyne S, Van Damme N, Smeets P, et al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br J Cancer. 2012;106:1926–1933. doi:10.1038/bjc.2012.18422596235
   PubMed Web of Science ®Google Scholar
• Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785–792. doi:10.1148/radiol.234304028615734934
   PubMed Web of Science ®Google Scholar